Received: 17 August 2018
Accepted: 14 January 2019
First Online: 29 January 2019
Ethics approval and consent to participate
: The study was done after the letter of ethical approval with a reference number of ERB/SOP/18/10/2018 was obtained from ethical review roard of School of Pharmacy, Addis Ababa University. All of the children at the HIV clinic who had been started on first line ART drugs based on the Ethiopia national guideline were included. Waiver of consent letter for this retrospective chart review was obtained from the Department of Pediatric and Child Health of TASH with a letter reference number: PD/SOM/206/10 to review patients’ charts for data collection. Privacy and confidentiality was strictly maintained throughout the whole process.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.